| Typicality: | 0.559 |
| Saliency: | 0.345 |
| in canada | 6 | location |
| worldwide | 3 | location |
| in the us | 3 | location |
| drug → be approved by → regulator | 20 |
| drug → be approved by → regulatory agencies | 6 |
| drug → be approved by → regulatory authorities | 5 |
| drug → be approved by → federal regulators | 5 |
| drug → be approved by → the regulator | 4 |
| negative | neutral | positive |
| 0.192 | 0.532 | 0.276 |
| Raw frequency | 40 |
| Normalized frequency | 0.345 |
| Modifier score | 1.000 |
| Perplexity | 108.579 |